{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:06:19Z","timestamp":1792760779425,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clgc.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T10:37:55Z","timestamp":1642156675000},"page":"297-297.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of 18 FDG- PET CT in the Management of Muscle Invasive Bladder Cancer"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-7498","authenticated-orcid":false,"given":"Pauline","family":"Bertolaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Brouste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Cazeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"de Clermont-Gallerande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bladou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Cabart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-3709","authenticated-orcid":false,"given":"Felix","family":"Lefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Gross-Goupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2022.01.009_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CEJ.0000000000000372","article-title":"Survival of solid cancer patients in France, 1989-2013: a population-based study","volume":"26","author":"Cowppli-Bony","year":"2017","journal-title":"Eur J Cancer prev"},{"key":"10.1016\/j.clgc.2022.01.009_bib0002","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/cncr.24466","article-title":"Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy","volume":"115","author":"Sonpavde","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2022.01.009_bib0003","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2022.01.009_bib0004","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1166-7087(20)30751-X","article-title":"French ccAFU guidelines \u2014 Update 2020- 2022: bladder cancer","volume":"30","author":"Roupr\u00eat","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000440889","article-title":"Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy","volume":"96","author":"Horn","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2022.01.009_bib0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.12659\/PJR.896752","article-title":"The role of computerized tomography in the assessment of perivesical invasion in bladder cancer","volume":"81","author":"Il","year":"2016","journal-title":"Pol J Radiol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0008","doi-asserted-by":"crossref","first-page":"W95","DOI":"10.2214\/AJR.17.18481","article-title":"The diagnostic performance of MRI for detection of lymph node metastasis in bladder and prostate cancer: an updated systematic review and diagnostic meta- analysis","volume":"210","author":"Woo","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0009","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2010.28.7052","article-title":"Clinical value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography\/Computed Tomography in Bladder Cancer","volume":"28","author":"Apolo","year":"2010","journal-title":"J Clin Oncol Sept"},{"key":"10.1016\/j.clgc.2022.01.009_bib0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/iju.12045","article-title":"18 Fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study: PET scan for bladder cancer","volume":"20","author":"Hitier-Berthault","year":"2013","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0011","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1200\/JCO.2008.20.6722","article-title":"Prospective study of [18 F] Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma","volume":"27","author":"Kibel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0012","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1007\/s00330-018-5959-0","article-title":"Integrated analysis of 18F-FDG PET\/CT improves preoperative lymph node staging for patients with invasive bladder cancer","volume":"29","author":"Girard","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000488200","article-title":"Diagnostic accuracy of F-18 FDG PET\/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: a systematic review and meta-analysis","volume":"95","author":"Ku Ha","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.clgc.2022.01.009_bib0014","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00345-018-2439-8","article-title":"Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis","volume":"37(4)","author":"Crozier","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bju.12109","article-title":"Impact of 18 Fluorodeoxyglucose (FDG)-positron-emission tomography\/computed tomography (PET\/CT) on management of patients with carcinoma invading bladder muscle: FDG-PET\/CT in carcinoma invading bladder muscle","volume":"112","author":"Mertens","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2022.01.009_bib0016","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/21681805.2014.990053","article-title":"[18 F]Fluorodeoxyglucose \u2013 positron emission tomography\/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy","volume":"49","author":"Kollberg","year":"2015","journal-title":"Scand J Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1442-2042.2012.02989.x","article-title":"Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in the detection of metastatic bladder cancer","volume":"19","author":"Yang","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.12608","article-title":"Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer: FDG pet in the staging of bladder cancer","volume":"114","author":"Goodfellow","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2022.01.009_bib0019","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.juro.2012.11.009","article-title":"FDG-positron emission tomography\/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer","volume":"189","author":"Mertens","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clgc.2018.05.008","article-title":"FDG-PET\/CT for assessing the response to neoadjuvant chemotherapy in bladder cancer patients","volume":"16","author":"Soubra","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2022.01.009_bib0021","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clgc.2021.03.002","article-title":"The Diagnostic Value of FDG-PET\/CT for Urachal Cancer","volume":"19(5)","author":"Stokkel","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2022.01.009_bib0022","unstructured":"NCCN Clinical Practice Guidelines in Oncology, Bladder Cancer. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf (Accessed 6 December, 2021)"},{"key":"10.1016\/j.clgc.2022.01.009_bib0023","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0024","first-page":"214","article-title":"Dual phase 18F-fluorodeoxyglucose positron emission tomography\/computed tomography with forced diuresis in diagnostic imaging evaluation of bladder cancer","volume":"32","author":"Yildirim-Poyraz","year":"2013","journal-title":"Rev Esp Med Nucl E Imagen Mol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0025","article-title":"Staging 18F-fluorodeoxyglucose positron emission tomography\/computed tomography changes treatment recommendation in invasive bladder cancer","volume":"11:S2588-9311(21)00029","author":"Voskuilen","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clgc.2022.01.009_bib0026","doi-asserted-by":"crossref","unstructured":"Abrahamsson J, Kollberg P, Almquist Helen, et\u00a0al. Compete metabolic response with FDG-PET predicts survival after induction chemotherapy in patients with clinically node positive bladder cancer. doi:10.1111\/BJU.15374.","DOI":"10.1111\/bju.15374"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:35:01Z","timestamp":1761564901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767322000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1558767322000209"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2022.01.009","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of 18 FDG- PET CT in the Management of Muscle Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}